Thomas Brannagan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas brannagan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Brannagan Today - Breaking & Trending Today

Global spread of COVID-19 has raised serious concern for patients with transthyretin amyloidosis


Global spread of COVID-19 has raised serious concern for patients with transthyretin amyloidosis
The global spread of COVID-19 has raised serious concern for patients with chronic disease. A correlation has been identified between the severity of COVID-19 and a patient s preexisting comorbidities.
Although COVID-19 primarily involves the respiratory system, dysfunction in multiple organ systems is common, particularly in the cardiovascular, gastrointestinal, immune, renal, and nervous systems.
Patients with transthyretin amyloidosis (ATTR) (a disease caused by an abnormal misfolded protein that causes buildup of amyloid deposits in the heart, peripheral nervous system including the autonomic nervous system, or other organs) represent a population particularly vulnerable to COVID-19 morbidity due to the multisystem nature of ATTR amyloidosis. ....

United States , Boston University , Frederick Ruberg , Emily Henderson , Bu Boston Medical Center Amyloidosis , Boston University School Of Medicine , Columbia University , Orphanet Journal , Rare Diseases , Study Corresponding Author , Associate Professor , Boston University School , Thomas Brannagan , Boston Medical Center Amyloidosis , ஒன்றுபட்டது மாநிலங்களில் , போஸ்டன் பல்கலைக்கழகம் , எமிலி ஹென்டர்சன் , போஸ்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , கொலம்பியா பல்கலைக்கழகம் , ரேர் நோய்கள் , இணை ப்ரொஃபெஸர் , போஸ்டன் பல்கலைக்கழகம் பள்ளி ,

ATTR amyloidosis during the COVID-19 Pandemic: Insights from a global medical roundtablp


 E-Mail
(Boston) The global spread of COVID-19 has raised serious concern for patients with chronic disease. A correlation has been identified between the severity of COVID-19 and a patient s preexisting comorbidities. Although COVID-19 primarily involves the respiratory system, dysfunction in multiple organ systems is common, particularly in the cardiovascular, gastrointestinal, immune, renal, and nervous systems. Patients with transthyretin amyloidosis (ATTR) (a disease caused by an abnormal misfolded protein that causes buildup of amyloid deposits in the heart, peripheral nervous system including the autonomic nervous system, or other organs) represent a population particularly vulnerable to COVID-19 morbidity due to the multisystem nature of ATTR amyloidosis. ....

United States , Boston University , Frederick Ruberg , Bu Boston Medical Center Amyloidosis , Boston University School Of Medicine , Columbia University , Orphanet Journal , Rare Diseases , Boston University School , Thomas Brannagan , Boston Medical Center Amyloidosis , ஒன்றுபட்டது மாநிலங்களில் , போஸ்டன் பல்கலைக்கழகம் , போஸ்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , கொலம்பியா பல்கலைக்கழகம் , ரேர் நோய்கள் , போஸ்டன் பல்கலைக்கழகம் பள்ளி ,